[
  {
    "ADA": [
      "Anti-drug antibodies"
    ]
  },
  {
    "ADCC": [
      "Antibody dependent cell-mediated cytotoxicity"
    ]
  },
  {
    "AE": [
      "Adverse event"
    ]
  },
  {
    "ALT": [
      "Alanine amino transferase"
    ]
  },
  {
    "Anti-VEGF": [
      "Anti-vascular endothelial growth factor"
    ]
  },
  {
    "AST": [
      "Aspartate amino transferase"
    ]
  },
  {
    "ATC": [
      "Anatomical-Therapeutic-Chemical classification"
    ]
  },
  {
    "AUC": [
      "Area under the curve"
    ]
  },
  {
    "AZA": [
      "Azathioprine"
    ]
  },
  {
    "BCVA": [
      "Best corrected visual acuity"
    ]
  },
  {
    "BRB": [
      "Blood-retinal barrier"
    ]
  },
  {
    "BUN": [
      "Blood urea nitrogen"
    ]
  },
  {
    "CBC": [
      "Complete blood count"
    ]
  },
  {
    "CHO": [
      "Chinese hamster ovary"
    ]
  },
  {
    "CINCA": [
      "Chronic Infantile Neurological Cutaneous Articular Syndrome"
    ]
  },
  {
    "CRF": [
      "Case Report Form"
    ]
  },
  {
    "CSA": [
      "Cyclosporine A"
    ]
  },
  {
    "CTCAE": [
      "Common Terminology Criteria for Adverse Events"
    ]
  },
  {
    "dL": [
      "Deciliter"
    ]
  },
  {
    "EAU": [
      "Experimental autoimmune uveitis/uveoretinitis"
    ]
  },
  {
    "EC": [
      "Ethics Committee"
    ]
  },
  {
    "ECG": [
      "Electrocardiogram"
    ]
  },
  {
    "ECL": [
      "Electrochemiluminescence"
    ]
  },
  {
    "EDC": [
      "Electronic data capture"
    ]
  },
  {
    "eCRF": [
      "Electronic case report form"
    ]
  },
  {
    "EIU": [
      "Endotoxin-induced uveitis"
    ]
  },
  {
    "EMA": [
      "European Medicines Agency"
    ]
  },
  {
    "ETDRS": [
      "Early treatment diabetic retinopathy study"
    ]
  },
  {
    "FFA": [
      "Fundus Fluorescein Angiography"
    ]
  },
  {
    "g/day": [
      "Grams per day"
    ]
  },
  {
    "g/dL": [
      "Grams per deciliter"
    ]
  },
  {
    "GCP": [
      "Good Clinical Practice"
    ]
  },
  {
    "GLP": [
      "Glucagon-like peptide or Good Laboratory Practice (note context)"
    ]
  },
  {
    "H1N1": [
      "Hemagglutinin type 1 and neuramimidase type 1"
    ]
  },
  {
    "HIV": [
      "Human immunodeficiency virus"
    ]
  },
  {
    "hs-CRP": [
      "High sensitivity C-reactive protein"
    ]
  },
  {
    "IC50": [
      "Half maximal inhibitory concentration"
    ]
  },
  {
    "ICH": [
      "International Conference on Harmonization"
    ]
  },
  {
    "ID": [
      "Identification"
    ]
  },
  {
    "INH": [
      "Isonicotinylhydrazine (also known as isoniazid)"
    ]
  },
  {
    "IRS": [
      "Interactive response system"
    ]
  },
  {
    "IUD": [
      "Intrauterine device"
    ]
  },
  {
    "IUSG": [
      "International Uveitis Study Group"
    ]
  },
  {
    "IV": [
      "Intravenous"
    ]
  },
  {
    "KD": [
      "Equilibrium dissociation constant"
    ]
  },
  {
    "kg": [
      "Kilograms"
    ]
  },
  {
    "Ltd": [
      "Limited"
    ]
  },
  {
    "mAb": [
      "Monoclonal antibody"
    ]
  },
  {
    "MedDRA": [
      "Medical Dictionary for Regulatory Activities"
    ]
  },
  {
    "mg": [
      "Milligrams"
    ]
  },
  {
    "mm": [
      "Millimeter"
    ]
  },
  {
    "mm3": [
      "Cubic millimeter"
    ]
  },
  {
    "MMF": [
      "Mycophenolate mofetil"
    ]
  },
  {
    "MPS": [
      "Mycophenolate sodium"
    ]
  },
  {
    "MRI": [
      "Magnetic Resonance Imaging"
    ]
  },
  {
    "MTX": [
      "Methotrexate"
    ]
  },
  {
    "NEI": [
      "National Eye Institute"
    ]
  },
  {
    "nM": [
      "Nanomolar"
    ]
  },
  {
    "NOAEL": [
      "No-observed-adverse-effect-level"
    ]
  },
  {
    "OCT": [
      "Optical coherence tomography"
    ]
  },
  {
    "OUD": [
      "Occurrence of uveitic disease"
    ]
  },
  {
    "PBMC": [
      "Peripheral blood mononuclear cell"
    ]
  },
  {
    "PD": [
      "Pharmacodynamic"
    ]
  },
  {
    "pH": [
      "Hydrogen ion concentration"
    ]
  },
  {
    "PK": [
      "Pharmacokinetic"
    ]
  },
  {
    "pM": [
      "Picomolar"
    ]
  },
  {
    "PO2": [
      "Oxygen pressure"
    ]
  },
  {
    "PPD": [
      "Purified protein derivative"
    ]
  },
  {
    "Q4W": [
      "Every 4 weeks"
    ]
  },
  {
    "QOL": [
      "Quality of life"
    ]
  },
  {
    "RA": [
      "Rheumatoid arthritis"
    ]
  },
  {
    "rHu": [
      "Recombinant human"
    ]
  },
  {
    "rMu": [
      "Recombinant mouse"
    ]
  },
  {
    "SAE": [
      "Serious adverse event"
    ]
  },
  {
    "SC": [
      "Subcutaneous"
    ]
  },
  {
    "SPR": [
      "Surface Plasmon Resonance"
    ]
  },
  {
    "SUN": [
      "Standardization of Uveitis Nomenclature"
    ]
  },
  {
    "TB": [
      "Tuberculosis"
    ]
  },
  {
    "TBD": [
      "To be determined"
    ]
  },
  {
    "TH1": [
      "T helper 1 cell"
    ]
  },
  {
    "TH17": [
      "T helper 17 cell"
    ]
  },
  {
    "TLR": [
      "Toll-like receptor"
    ]
  },
  {
    "TNFÎ±": [
      "Tumor necrosis factor alpha"
    ]
  },
  {
    "T2D": [
      "Type 2 diabetes"
    ]
  },
  {
    "ULN": [
      "Upper limit of normal"
    ]
  },
  {
    "WBC": [
      "White blood cell (count)"
    ]
  },
  {
    "WHODD": [
      "World Health Organization Drug Dictionary"
    ]
  },
  {
    "WMA": [
      "World Medical Association"
    ]
  }
]